Maarten de Wit

EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2019 update

Josef S Smolen, Robert Landewé, J. W. J. Bijlsma et al. · Annals of the Rheumatic Diseases · 2020 · 2.8K citations · Full text

Medicine, Internal Medicine, Pharmacotherapy +15

EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2013 update

Josef S Smolen, Robert Landewé, Ferdinand C. Breedveld et al. · Annals of the Rheumatic Diseases · 2013 · 1.8K citations · Full text

Medicine, Internal Medicine, Pharmacotherapy +15

American College of Rheumatology/European League Against Rheumatism provisional definition of remission in rheumatoid arthritis for clinical trials

David T. Felson, Josef S Smolen, George A. Wells et al. · Arthritis & Rheumatism · 2011 · 1K citations · Full text

Medicine, Clinical Sciences, Autoimmunity +13

Shared decision making: really putting patients at the centre of healthcare

Anne M. Stiggelbout, Trudy van der Weijden, Maarten de Wit et al. · BMJ · 2012 · 1K citations · Full text

Nursing, Health Services Administration, Decision Making +11

EULAR recommendations for the management of psoriatic arthritis with pharmacological therapies: 2019 update

Laure Gossec, Xenofon Baraliakos, Andreas Kerschbaumer et al. · Annals of the Rheumatic Diseases · 2020 · 948 citations · Full text

Medicine, Internal Medicine, Pharmacotherapy +16